Navigation Links
Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease
Date:5/20/2010

Through Existence’s cutting-edge technological advancements, prediction and prevention of a wide range of both common and rare diseases are possible before they ever manifest. The future of medicine starts today.

(PRWEB) May 20, 2010 -- Welcome your new Existence! Existence Genetics LLC, the world’s first predictive medicine company, is working with healthcare providers to PREDICT, PREVENT, and PREVAIL over disease.

Founded in 2005 by a team of physicians, Existence Genetics is pioneering the field of predictive medicine by providing Genetically Tailored Technology to the health care industry. Existence provides health care professionals with access to groundbreaking predictive medicine services and delivers understandable, useful, and personalized solutions to protect and preserve their patients’ health. Rather than simply handing bewildering results to an untrained patient, the goal of Existence is to empower health care professionals with genetic technology so that they can efficiently integrate genetic screening into their practice and provide cutting-edge predictive medicine services to their patients. Because of this, Existence provides its services only through health care professionals and not direct to the consumer (DTC) or over the counter (OTC).

Existence has developed patent-pending Nexus technologies to enable comprehensive genetic testing and analysis that focuses on the personalized prevention of disease. The Nexus technologies include a proprietary, highly advanced gene chip known as the Nexus Gene Chip. This first-of-its-kind, highly accurate gene chip allows cost-effective, time-efficient screening for hundreds of potential disease predispositions as well as for genes that are involved in the prevention and treatment of disease, thereby enabling the advent of genetically tailored prevention. The results provided by the Nexus Gene Chip are analyzed by the Nexus IT system, which uses patent-pending technologies such as the disease matrix, reflex analysis, panel screening, and next-generation genetic reports to provide health care professionals with straightforward, genetically-tailored solutions for their patients.

Existence’s Nexus technologies make predictive medicine straightforward, understandable, useful, and personalized. Existence’s One Genome philosophy means that we focus on all diseases regardless of their prevalence and screen simultaneously for hundreds of rare and common diseases. And because its Nexus technologies were developed with this philosophy in mind, Existence will be the first company that is able to provide full genome clinical analysis of full genome sequencing data.

In addition, Existence’s newest technology, the Pythia Approach, which is now in its final stages of development, combines the genetic analysis of two potential parents to determine the disease predispositions and traits their yet-to-be-conceived offspring are likely to inherit.

Through Existence’s cutting-edge technological advancements, prediction and prevention of a wide range of both common and rare diseases are possible before they ever manifest. The future of medicine starts today.

Existence Genetics has offices in California and New York, with headquarters in Los Angeles. To learn more about Existence Genetics and the Nexus technologies, visit www.existencegenetics.com.

###

Read the full story at http://www.prweb.com/releases/existencegenetics/may2010/prweb4025124.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Georgia DUI Lawyers Scramble to Publicize Existence of New Appeal Fee of $150 for All DUI-Related Administrative License Suspension Cases
2. Medco Acquires Leading Genetics Healthcare Company, DNA Direct
3. New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies
4. Chicago Cancer Genome Project studies genetics of 1,000 tumors
5. Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York
6. Interleukin Genetics, Inc. and Stanford University Report Genetic Test Improves Weight Loss Success With Diets
7. Study finds changes in fetal epigenetics throughout pregnancy
8. Genetics, Psychology May Trigger ADHD
9. Resveratrol Supplement Company RevGenetics Welcomes New Chief Science Officer
10. Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health
11. Cancer genetics pioneer wins Margaret Kripke Legend Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Existence Genetics is Pioneering the Field of Predictive Medicine -  Nexus Technologies Critical in Understanding and Preventing Deadly Disease 
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
Breaking Medicine Technology: